Ethnicity | Sensitivity (95% CI) | Specificity (95% CI) | LR + ve (95% CI) | LR -ve (95% CI) |
---|---|---|---|---|
a) ABPM v Clinic23 on three occasions (thresholds: ABPM 135/85 mmHg, Clinic23 140/90 mmHg) | ||||
All sample (n = 340) | 41.4% (33.7–49.4%) | 89.3% (83.8–93.4%) | 3.87 (2.44–6.16) | 0.66 (0.57–0.75) |
WB (n = 148) | 39.7% (28.5–51.9%) | 89.3% (80.1–95.3%) | 3.72 (1.82–7.60) | 0.67 (0.55–0.83) |
SA (n = 92) | 34.1% (20.1–50.6%) | 86.3% (73.7–94.3%) | 2.49 (1.11–5.59) | 0.76 (0.60–0.98) |
AC (n = 100) | 50.0% (35.2–64.8%) | 92.3% (81.5–97.9%) | 6.50 (2.43–17.37) | 0.54 (0.40–0.73) |
b) ABPM v Clinic26 on three occasions (thresholds: ABPM 135/85 mmHg, Clinic26 135/85 mmHg) | ||||
All sample (n = 340) | 61.1% (53.1–68.7%) | 78.7% (71.9–84.4%) | 2.86 (2.1–3.89) | 0.49 (0.40–0.61) |
WB (n = 148) | 57.5% (45.4–69.0%) | 73.3% (61.9–82.9%) | 2.16 (1.41–3.30) | 0.58 (0.43–0.78) |
SA (n = 92) | 58.5% (42.1–73.7%) | 78.4% (64.7–88.7%) | 2.71 (1.51–4.86) | 0.53 (0.36–0.78) |
AC (n = 100) | 68.8% (53.7–81.3%) | 86.5% (74.2–94.4%) | 5.11 (2.50–10.44) | 0.36 (0.23–0.56) |
c) ABPM v ClinicD1R1 (thresholds: ABPM 135/85 mmHg, ClinicD1R1 140/90 mmHg) | ||||
All sample (n = 340) | 44.4% (36.6–52.4%) | 59.0% (51.4–66.3%) | 1.08 (0.85–1.39) | 0.94 (0.78–1.13) |
WB (n = 148) | 46.6% (34.8–58.6%) | 60.0% (48.0–71.1%) | 1.16 (0.80–1.69) | 0.89 (0.67–1.18) |
SA (n = 92) | 29.3% (16.1–45.5%) | 60.8% (46.1–74.2%) | 0.75 (0.42–1.34) | 1.16 (0.87–1.56) |
AC (n = 100) | 54.2% (39.2–68.6%) | 55.8% (41.3–69.5%) | 1.22 (0.82–1.83) | 0.82 (0.56–1.22) |
d) ABPM v Home-monitoring for 1 week (thresholds: ABPM 135/85 mmHg, Home 135/85 mmHg) | ||||
All sample (n = 340) | 84.0% (77.4–89.2%) | 62.4% (54.8–69.5%) | 2.23 (1.82 –2.73) | 0.26 (0.18–0.37) |
WB (n = 148) | 80.8% (69.9–89.1%) | 65.3% (53.5–76.0%) | 2.33 (1.68 –3.24) | 0.29 (0.18–0.48) |
SA (n = 92) | 85.4% (70.8–94.4%) | 54.9% (40.3–68.9%) | 1.89 (1.36–2.63) | 0.27 (0.12–0.58) |
AC (n = 100) | 87.5% (74.8–95.3%) | 65.4% (50.9–78.0%) | 2.53 (1.71–3.73) | 0.19 (0.09–0.41) |